Authors: Malaguarnera, M Restuccia, S Ferlito, L Mazzoleni, G Giugno, I Pistone, G

Citation: M. Malaguarnera et al., Antiviral drugs in chronic hepatitis B: review and meta-analysis, INT J CL PH, 39(1), 2001, pp. 4-11

Authors: Malaguarnera, L Ferlito, L Di Mauro, S Imbesi, RM Scalia, G Malaguarnera, M

Citation: L. Malaguarnera et al., Immunosenescence and cancer: a review, ARCH GER G, 32(2), 2001, pp. 77-93

Authors: Malaguarnera, L Ferlito, L Imbesi, RM Gulizia, GS Di Mauro, S Maugeri, D Malaguarnera, M Messina, A

Citation: L. Malaguarnera et al., Immunosenescence: a review, ARCH GER G, 32(1), 2001, pp. 1-14

Authors: Malaguarnera, M Ferlito, L Gulizia, G Di Fazio, I Pistone, G

Citation: M. Malaguarnera et al., Use of interleukin-2 in advanced renal carcinoma: meta-analysis and reviewof the literature, EUR J CL PH, 57(4), 2001, pp. 267-273

Authors: Malaguarnera, M Di Fazio, I Ferlito, L Pistone, G Laurino, A Vinci, E Mazzoleni, G

Citation: M. Malaguarnera et al., Increase of serum beta 2-microglobulin in patients affected by HCV correlated hepatocellular carcinoma, EUR J GASTR, 12(8), 2000, pp. 937-939

Authors: Malaguarnera, M Restuccia, S Di Fazio, I Zoccolo, AM Ferlito, L Bentivegna, P

Citation: M. Malaguarnera et al., Serum carnitine levels in chronic hepatitis C patients before and after lymphoblastoid interferon-alpha treatment, BIODRUGS, 12(1), 1999, pp. 65-69